TYRA

Tyra Biosciences Inc
NASDAQHEALTHCAREBIOTECHNOLOGY

Key Statistics

Market Cap
$2.14B
P/E Ratio
EPS
$-2.18
Beta
0.79
52W High
$40.65
52W Low
$8.75
50-Day MA
$36.02
200-Day MA
$23.90
Dividend Yield
Profit Margin
0.00%
Forward P/E
PEG Ratio

About Tyra Biosciences Inc

Tyra Biosciences, Inc., a preclinical-stage biopharmaceutical company, focuses on developing therapies to overcome tumor resistance and improve outcomes for cancer patients. The company is headquartered in Carlsbad, California.

Official WebsiteUSAFY End: December

Fundamentals

Revenue (TTM)0
Gross Profit (TTM)0
EBITDA$-142.37M
Operating Margin0.00%
Return on Equity-36.90%
Return on Assets-23.60%
Revenue/Share (TTM)$0.00
Book Value$4.83
Price-to-Book7.89
Price-to-Sales (TTM)
EV/Revenue-
EV/EBITDA-6.95
Quarterly Earnings Growth (YoY)0.00%
Quarterly Revenue Growth (YoY)0.00%
Shares Outstanding$59.47M
Float$30.74M
% Insiders2.86%
% Institutions96.38%

Historical Volatility

HV 10-Day
44.63%
HV 20-Day
50.52%
HV 30-Day
45.63%
HV 60-Day
51.26%
HV Rank
2.8%

Volatility is currently contracting

Analyst Ratings

Consensus ($51.15 target)
2
Strong Buy
11
Buy

More HEALTHCARE Stocks

Data last updated: 5/16/2026